Ozempic is transforming your gym - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
FT商学院

Ozempic is transforming your gym

Weight-loss drugs and a new focus on wellness are pushing many exercise machines towards obsolescence

Hold tight to your free weights — the Ozempic revolution is coming to a gym near you.

The runaway success of “GLP-1” weight loss and diabetes drugs, which also include Wegovy and Zepbound, is hard to overstate. Sales are expected to approach $50bn this year, making them the top-selling class of drugs worldwide. That is despite global shortages, high prices and the fact that the drugs are largely available only in injectable form so far. Sales are expected to more than double to $130bn by 2030 and could soar higher if the makers win permission to sell them as a preventive tool.

For pharma groups Novo Nordisk and Eli Lilly, soon to be joined by others, this is fabulous news. For others, it is likely to be really bad. Diet company WeightWatchers recently changed chief executives as it struggles to adjust, and soft drink, beer and snack company shares have been on a wild ride as investors try to figure out who will be hurt the most when consumers taking the drugs eat healthier food and fewer calories overall.

For gyms and health clubs, the impact is going to be huge but complicated for an industry that is still rebuilding after Covid. The pandemic put a quarter of US fitness centres out of business and reshaped commuting and exercise patterns. Weight-loss drugs are likely to supercharge a consumer rush towards strength training equipment that has been gaining force for more than a decade, and many gyms are still ill-prepared.

Ten years ago, most health club floors were seas of treadmills, elliptical machines and stationary bikes, with fixed weight machines along the edges along with a free weight area geared towards power lifting, mostly by men. But the pandemic and concurrent rise of apps and YouTube videos that gave people access to personalised fitness routines has made that configuration all but obsolete.

Customers still use treadmills but both sexes now seek out a wider range of strength training equipment, including barbells, dumbbells, medicine balls and the like. Clubs, seeking to boost membership, have also leaned into the social aspects of in-person fitness, from group classes and personal trainers to cafés and hang-out areas.

Gyms are pushing their stair climbers and fixed weight machines to the periphery and replacing them with open space for body-sculpting classes, free weights and individual training sessions.

“We’re seeing a greater demand for space for strength,” Colleen Keating, CEO of Planet Fitness, one of the largest listed gym groups, told analysts in August. Even Peloton, famous for its cardio-intensive bikes, is testing an app focused on strength training.

The shift takes time and money. The now less-popular cardio machines are often sold on multiyear leases, while strength training equipment generally requires an upfront investment. The delay is leading to uneven usage and customer complaints at clubs that have not made the shift.

Weight-loss drugs will exacerbate the pressure. As the drugs gain acceptance, fewer people are likely to rely on exercise as their primary weight loss tool and the drugs’ side effects, nausea and intestinal distress, can make high-impact cardio activities uncomfortable.

However, GLP-1 users still need the gym. Studies suggest that the drugs cause significant muscle loss along with fat, leading to problems with balance and mobility as well as saggy skin sometimes dubbed “Ozempic butt”.

Strength training seems to be the answer not just for GLP-1 users but everyone else. A growing body of medical literature suggests strength training cuts mortality, particularly for women, while also helping to prevent osteoporosis and relieving the symptoms of depression.

“It’s gone from being health and fitness to health and wellness, which is a lot more holistic” says Eleanor Scott, a partner on PwC’s leisure strategy team.

Foot traffic to popular US gym chains Crunch Fitness and EoS Fitness is up by double-digits year on year, according to data provider Plaicer.ai. Planet Fitness has added 2.7mn members since the start of 2023 and improved its profit margins.

For all of them, the combination of strength training with prevention creates a chance to win, or win back, older customers still wary of gyms post-Covid. Although 80 per cent of baby boomers participate in fitness activities, just 42 per cent belong to a gym, compared to nearly three-quarters of active Gen Zers and millennials, according to ABC Fitness. But growth will not follow if newcomers end up fighting the regulars for access to the dumbbells.

brooke.masters@ft.com

Follow Brooke Masters with myFT and on X

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

再次陷入危机的大众汽车能走上改革之路吗?

欧洲最大的汽车制造商正与工人和政界人士交战,试图渡过痛苦的电动汽车转型期。

哈里斯的另一个大选对手:通货膨胀

美国选民对高昂生活成本的不满可能决定下周谁将赢得白宫。

Lex专栏:Meta和微软通过季度理智检查

科技巨头今天吹捧真正的胜利,以证明明天的巨额投资是合理的。投资者对此是支持的,但程度有限。

FT社评:英国工党预算——雄心勃勃,前景不明

财政大臣蕾切尔•里夫斯现在必须兑现她的投资计划,否则税收还将进一步增加。

Lex专栏:大众汽车很难走出死胡同

尽管这家汽车制造商计划裁员和关闭工厂,但投资者的担忧是可以理解的。

安谋如何成为人工智能投资热潮中的意外赢家

这家由软银控股的英国芯片设计公司的股价在过去一年上涨了两倍。但它的野心远不止于此。
设置字号×
最小
较小
默认
较大
最大
分享×